{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "FBIN",
  "name": "Fortune Brands Innovations, Inc.",
  "url": "https://orbyd.app/dossiers/FBIN/",
  "json_url": "https://orbyd.app/dossiers/FBIN.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Activist-plus-new-CEO turnaround has stopped accelerating and started digesting: after the +30% run off Garden's $40.6 buy, price has chopped $50–54 for three weeks while sell-side targets climbed past spot (Goldman $61 on 7/10, Barclays $56 on 7/14). The 2026-08-04 Q2 print is the binary that decides whether the base resolves up.",
  "invalidation_trigger": "A weekly close below $49 breaks the July consolidation shelf and returns price to the pre-CEO-announcement $44–46 base; a 2026-08-04 Q2 print with sales still down YoY and no margin inflection or Singh strategic framework would confirm the re-rating ran ahead of the numbers.",
  "catalyst_date": "2026-08-04",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "housing-homebuilders-proptech"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Two thesis pillars to monitor: Jesse Singh (ex-AZEK) as CEO and Edward Garden/Trian's board stake — track follow-on Form 4s for whether insiders keep buying above $50 or stopped near $40.",
    "Ran ~+30% off the $40.6 activist buy in ~3 weeks; overbought per the 2026-07-01 RSI flag",
    "Narrative graduated from 'momentum + social spike, no story' (2026-07-01) to a real activist/new-CEO turnaround; conviction gated by price extension, not by thesis quality.",
    "Q2 2026 results confirmed for after the close on 2026-08-04 (company IR release), with a 5:00pm ET call — this supersedes the earlier ~08-04 estimate and any third-party 07-30 listing. Blackout logic should treat 08-04 as hard.",
    "CFO seat is still interim — Ashley George listed as Interim CFO on the Q2 call roster. A permanent CFO hire is the next org datapoint; Singh appointing his own finance chief would be a genuine execution signal.",
    "Singh inducement awards effective 2026-07-01: 850,000 performance-based RSUs plus 300,000 service-based options. The PSU-heavy mix means the new CEO's payout is levered to share price, not tenure.",
    "Track follow-on Form 4s: Garden bought at $40.6. Whether he or other directors add above $50 separates a one-off statement buy from sustained insider accumulation.",
    "Price has now spent three weeks between roughly $50 and $54.5 without giving back the breakout — the extension complaint from early July has been resolved by time rather than by a pullback into the $46–48 zone."
  ],
  "body_markdown": "## Current Thesis\nThe story is unchanged from late June; the tape has changed character. Trian co-founder and director Edward Garden bought 320,067 shares (~$13M) at $40.6 on 2026-06-11, ex-AZEK chief Jesse Singh was named CEO effective 2026-06-29, and Truist upgraded to Buy with a $70 target on 2026-06-30. That sequence produced a ~+30% move to ~$54.5. Since then, nothing: the stock has traded a $50–54 range for three weeks, closing around $52.62 on 2026-07-16. The impulse leg is over and a base has formed on top of the breakout rather than a retest back into it.\n\nWhat did move was the analyst stack. Goldman Sachs reiterated Buy and raised its target to $61 on 2026-07-10; Barclays lifted its Equal-Weight target to $56 on 2026-07-14. Spot now sits below four of five published targets, where three weeks ago it sat above all but one. The models have caught up to the price, which removes the \"trading above every mark\" objection but also means the easy re-rating on paper is done. Everything from here is execution, and the first read on execution is the Q2 print after the close on 2026-08-04 — Singh's first call as CEO.\n\n## Bull Case\n- Insider conviction at the lows: Garden Form 4, 320,067 shares at $40.6, ~$13M, 2026-06-11. An activist principal with a board seat committing personal capital near multi-year lows is the highest-quality signal in the file, and it was placed roughly 25% below current spot.\n- Operator with a matching track record: Singh ran The AZEK Company 2016–2025, where revenue roughly tripled and EBITDA margins expanded materially before the James Hardie takeout. He arrives at a building-products company with the same margin-and-portfolio playbook already proven in the same end market.\n- Pay is levered to the stock: inducement awards effective 2026-07-01 were 850,000 performance-based RSUs and 300,000 service-based options. The weighting toward PSUs ties the new CEO's outcome to share price rather than time served.\n- Target cluster now brackets spot from above: Truist $70 (Buy, 2026-06-30), Goldman $61 (Buy, 2026-07-10), Barclays $56 (Equal-Weight, 2026-07-14) against Evercore $48 (In-Line, 2026-06-30). Four separate desks revised upward inside a 14-day window.\n- De-rated cyclical with real franchises: Moen and House of Rohl in Water, Therma-Tru and Fiberon in Outdoors, Master Lock and Yale/August in Security. Market cap ~$6.1B against a 52-week range of $32.34–$64.84 — the stock is still 19% below where it traded a year ago, so the recovery has retraced a fraction of the de-rating.\n\n## Bear Case\n- Momentum has stalled. Three weeks of $50–54 chop after a vertical move is either accumulation or distribution, and there is no volume-confirming break either way yet. A name whose narrative is genuinely accelerating usually does not spend three weeks flat.\n- The fundamentals have not turned. Q1 2026 sales were $1.0B, down 2% YoY (reported 2026-05-07). Nothing in the tape reflects a data point; it reflects two personnel and one ownership event.\n- Binary sits directly ahead. Q2 results land after the close on 2026-08-04 with a 5:00pm ET call. Buying a stock that already ran 30% on promise, into the print that first tests the promise, is the wrong side of the risk.\n- The finance seat is unfilled. Ashley George is listed as Interim CFO on the Q2 call roster. A turnaround without a permanent CFO cannot credibly issue a multi-year margin framework, which caps how much Singh can say on 8/4.\n- Dispersion is wide because the outcome is unknown. Truist $70 versus Evercore $48 is a 46% spread. That is not a consensus re-rating; it is two desks disagreeing about whether the plan exists.\n- Portfolio overhang persists. The Yale/August connected-products business has dragged margins and returns. Fixing or divesting it is a multi-quarter project that will show up in charges before it shows up in EPS.\n\n## Setup & Price Structure\n- Last ~$52.62 (2026-07-16). Range since the CEO announcement: roughly $50.01–$54.53, with a 4.2% day to $51.61 on 2026-07-10 on the Goldman raise.\n- Zones by origin: activist accumulation $40–41 (Garden buy 2026-06-11); pre-catalyst base $44–46; CEO-announcement breakout shelf $46–48; current consolidation floor ~$50.\n- The $46–48 retest flagged in early July never arrived. Price resolved the overbought condition sideways instead, which is the stronger outcome structurally but leaves no discount entry.\n- Spot trades under Barclays $56, Goldman $61 and Truist $70, and above Evercore $48. The gap between price and the bullish targets is the entire remaining thesis, and it does not close without numbers.\n- Valuation ~22.9x trailing earnings with a 1.98% dividend yield. Not cheap for a company with sales declining 2% YoY; the multiple already embeds a recovery.\n- Practical read: the constructive window is the reaction to 2026-08-04, not the eleven trading days in front of it. A break above $54.5 before the print would be a chase into a binary; a slide under $50 would say the base was distribution.\n\n## Catalyst Calendar (next 30 days)\n\n- **Ongoing** — permanent CFO announcement. Unscheduled, but a hire before or on the Q2 call would materially raise the odds that a strategic framework follows in the second half.\n- **Ongoing** — housing and repair-and-remodel prints (existing-home sales, builder sentiment). Big-ticket remodel demand remains rate-hostage and drives the top line regardless of who runs the company.\n\n## Elapsed catalysts\n\n- **2026-08-04 (confirmed)** — Q2 2026 results after market close, conference call 5:00pm ET. Singh's first call as CEO, alongside COO David Barry and Interim CFO Ashley George. Watch for: whether sales stop declining against the -2% YoY Q1 comp, any framing of a margin or portfolio program, and whether full-year guidance is reset. *(passed 5d ago)*\n- **Ongoing through 2026-08-04** — Form 4 filings. Whether Garden or other directors add above $50 versus stopping at $40.6 is the cleanest available read on internal conviction at the new price. *(passed 5d ago)*\n\n## What Would Change Our Mind\n- A weekly close below $49 breaks the July consolidation floor and returns price into the pre-CEO $44–46 base, which would mean the three-week range was distribution by holders who bought the headline.\n- A Q2 print on 2026-08-04 showing sales still down YoY with no margin inflection and no strategic framework from Singh confirms the re-rating priced a plan that does not yet exist. Full-year guidance cut on that call would be the harder version of the same signal.\n- Garden and the board going quiet — no follow-on Form 4 buying through the print — would mark the $40.6 purchase as a one-time statement rather than the start of accumulation.\n- On the other side: a print that stabilizes revenue, pairs with a credible margin or portfolio program, and holds a close above $54.5 would flip this from a stalled base into a resumed trend and justify a materially higher-conviction stance.\n\n## Correlation Notes\n- Trades with building products and repair-and-remodel: MAS, MHK, AZEK's former peer set, and the retail channel through HD and LOW. Sector-wide weakness on a rate backup will overwhelm any company-specific turnaround progress.\n- Rate-sensitive by construction. The Water and Outdoors segments key off housing turnover and big-ticket discretionary remodel, both of which improve on falling long-end yields. A hawkish repricing hits this name harder than the broad industrial complex.\n- Sits inside the small-cap-value and cyclical-industrials rotation rather than leading it. Relative strength versus MAS and the homebuilder complex is the honest test of whether the activist-plus-CEO story is adding anything above beta.\n- Idiosyncratic overlay: activist special situations and new-CEO turnarounds decouple from sector beta when execution news lands. Between news events, the correlation to housing cyclicals reasserts, which is where the name has traded for the last three weeks.",
  "first_seen": "2026-07-01",
  "last_analyzed": "2026-07-24T06:10:23+00:00",
  "last_synthesized": "2026-07-19",
  "last_update_source": "theme_discovery",
  "license": "Content © orbyd. Cite the canonical URL."
}